CIGAR‐seq, a CRISPR/Cas‐based method for unbiased screening of novel mRNA modification regulators
Liang Fang,Wen Wang,Guipeng Li,Li Zhang,Jun Li,Diwen Gan,Jiao Yang,Yisen Tang,Zewen Ding,Min Zhang,Wenhao Zhang,Daqi Deng,Zhengyu Song,Qionghua Zhu,Huanhuan Cui,Yuhui Hu,Wei Chen
DOI: https://doi.org/10.15252/msb.202010025
IF: 13.068
2020-11-01
Molecular Systems Biology
Abstract:<p>Cellular RNA is decorated with over 170 types of chemical modifications. Many modifications in mRNA, including m<sup>6</sup>A and m<sup>5</sup>C, have been associated with critical cellular functions under physiological and/or pathological conditions. To understand the biological functions of these modifications, it is vital to identify the regulators that modulate the modification rate. However, a high‐throughput method for unbiased screening of these regulators is so far lacking. Here, we report such a method combining pooled CRISPR screen and reporters with RNA modification readout, termed <span>C</span>RISPR <span>i</span>ntegrated <span>g</span>RNA <span>a</span>nd <span>r</span>eporter sequencing (CIGAR‐seq). Using CIGAR‐seq, we discovered NSUN6 as a novel mRNA m<sup>5</sup>C methyltransferase. Subsequent mRNA bisulfite sequencing in HAP1 cells without or with NSUN6 and/or NSUN2 knockout showed that NSUN6 and NSUN2 worked on non‐overlapping subsets of mRNA m<sup>5</sup>C sites and together contributed to almost all the m<sup>5</sup>C modification in mRNA. Finally, using m<sup>1</sup>A as an example, we demonstrated that CIGAR‐seq can be easily adapted for identifying regulators of other mRNA modification.</p>
biochemistry & molecular biology